Management of bacterial and fungal infections in bone marrow transplant recipients and other granulocytopenic patients
- PMID: 3052842
Management of bacterial and fungal infections in bone marrow transplant recipients and other granulocytopenic patients
Abstract
A review of studies on the effect of different types of gastrointestinal decontamination and protective environment on infectious complications in granulocytopenic patients is given, and the effect of these measures on graft-versus-host disease after allogeneic bone marrow transplantation is discussed. It is concluded that complete gastrointestinal decontamination of patients nursed under conditions of strict reverse isolation will maximally prevent infections, graft-versus-host disease, and lung complications and therefore is the treatment to be preferred for patients undergoing bone marrow transplantation. Since selective decontamination is as effective in preventing bacterial and fungal infections as is complete decontamination, this treatment is to be preferred for other patients with a greatly reduced resistance to these infections. The reason is that, for this type of patient, selective decontamination can be performed without the use of strict isolation facilities and in this way is less laborious and less of a burden for the patient. Besides this, the number of patients that can be treated will not be limited by the number of available facilities for strict reverse isolation, which can be reserved for bone marrow transplant patients.
Similar articles
-
Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation.Eur J Clin Microbiol Infect Dis. 1990 Jan;9(1):14-23. doi: 10.1007/BF01969527. Eur J Clin Microbiol Infect Dis. 1990. PMID: 2105890
-
Gastrointestinal decontamination of dogs treated with total body irradiation and bone marrow transplantation.Exp Hematol. 1981 Oct;9(9):904-16. Exp Hematol. 1981. PMID: 7040095
-
New approaches to the prophylaxis and treatment of bacterial and fungal infections in allogeneic marrow transplant recipients.Bone Marrow Transplant. 1994;14 Suppl 4:S61-5. Bone Marrow Transplant. 1994. PMID: 7728128 Review.
-
Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.Bone Marrow Transplant. 1993 Sep;12(3):283-8. Bone Marrow Transplant. 1993. PMID: 8241988 Clinical Trial.
-
Acute graft-versus-host disease after allogeneic bone marrow transplantation.Can Med Assoc J. 1983 Nov 1;129(9):969-74. Can Med Assoc J. 1983. PMID: 6367917 Free PMC article. Review.
Cited by
-
Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation.Life (Basel). 2021 Jan 29;11(2):102. doi: 10.3390/life11020102. Life (Basel). 2021. PMID: 33572932 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical